• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A、C、Y 和 W-135 群脑膜炎球菌结合疫苗。

Meningococcal group A, C, Y and W-135 conjugate vaccine.

机构信息

Infectious Diseases Epidemiology Research Unit, University of Pittsburgh Graduate School of Public Health and School of Medicine, Pittsburgh, Pennsylvania 15101, USA.

出版信息

Nat Rev Drug Discov. 2010 Jun;9(6):429-30. doi: 10.1038/nrd3194.

DOI:10.1038/nrd3194
PMID:20514064
Abstract

In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in people aged 11-55 years.

摘要

2010 年 2 月，美国食品药品监督管理局批准了一种四价结合疫苗（Menveo；诺华疫苗和诊断公司），用于预防侵袭性脑膜炎奈瑟菌血清群 A、C、Y 和 W-135 引起的 11-55 岁人群的疾病。

相似文献

1
Meningococcal group A, C, Y and W-135 conjugate vaccine.A、C、Y 和 W-135 群脑膜炎球菌结合疫苗。
Nat Rev Drug Discov. 2010 Jun;9(6):429-30. doi: 10.1038/nrd3194.
2
Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.脑膜炎球菌四价（A、C、W135和Y血清群）结合疫苗（Menveo(®)）：简介报告
Paediatr Drugs. 2012 Feb 1;14(1):63-5. doi: 10.2165/11206930-000000000-00000.
3
Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.用于从婴儿期起提供更广泛保护的四价ACYW-135脑膜炎球菌结合疫苗。
Expert Rev Vaccines. 2009 May;8(5):529-42. doi: 10.1586/erv.09.18.
4
Immunisation update: Meningococcal B and ACWY vaccines.免疫接种最新情况：B型脑膜炎球菌疫苗和ACWY疫苗
J Fam Health. 2015 Nov-Dec;25(6):22-5.
5
Safety and immunogenicity of meningococcal ACWY CRM197-conjugate vaccine in children, adolescents and adults in Russia.俄罗斯儿童、青少年和成人中脑膜炎球菌 ACWY CRM197 结合疫苗的安全性和免疫原性。
Hum Vaccin Immunother. 2014;10(8):2471-81. doi: 10.4161/hv.29571.
6
Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims.朝觐者中A、C、W和Y血清群脑膜炎球菌血清杀菌抗体谱
Int J Infect Dis. 2014 Nov;28:171-5. doi: 10.1016/j.ijid.2014.09.005. Epub 2014 Oct 12.
7
A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.一项评估幼儿使用不同配方的四价脑膜炎球菌（A、C、Y 和 W-135）结合破伤风蛋白疫苗的安全性和免疫原性的随机试验。
Pediatr Infect Dis J. 2012 Jan;31(1):e15-23. doi: 10.1097/INF.0b013e31823e1e34.
8
[Meningococcal vaccines: from polysaccharide to conjugate vaccines].[脑膜炎球菌疫苗：从多糖疫苗到结合疫苗]
Arch Pediatr. 2012 Sep;19 Suppl 2:S61-4. doi: 10.1016/S0929-693X(12)71275-7.
9
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.A 组、C 组、Y 组和 W-135 组脑膜炎球菌多糖-白喉类毒素结合疫苗在人类免疫缺陷病毒感染青少年中的 I/II 期、开放性、安全性和免疫原性试验。
Pediatr Infect Dis J. 2010 May;29(5):391-6. doi: 10.1097/INF.0b013e3181c38f3b.
10
Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and Youth.四价脑膜炎球菌结合疫苗加强免疫在既往免疫的 HIV 感染儿童和青少年中的免疫原性。
J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e69-e74. doi: 10.1093/jpids/piw094.

引用本文的文献

1
Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants.非侵入性疫苗：制剂和疫苗佐剂方面的挑战
Pharmaceutics. 2023 Aug 9;15(8):2114. doi: 10.3390/pharmaceutics15082114.
2
Carrier Proteins Facilitate the Generation of Antipolysaccharide Immunity via Multiple Mechanisms.载体蛋白通过多种机制促进抗多糖免疫的产生。
mBio. 2022 Jun 28;13(3):e0379021. doi: 10.1128/mbio.03790-21. Epub 2022 Apr 14.
3
Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies.细胞质糖基工程使纳米级糖蛋白组装体的生物合成成为可能。

本文引用的文献

1
Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.脑膜炎球菌结合疫苗（Menveo）许可和使用指南-免疫实践咨询委员会（ACIP），2010 年。
MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):273.
2
Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.一剂 MenACWY-CRM（一种研究性四价脑膜炎球菌糖结合疫苗）在青少年中同时或序贯接种 Tdap 和 HPV 疫苗的安全性和免疫原性。
Vaccine. 2010 Apr 19;28(18):3171-9. doi: 10.1016/j.vaccine.2010.02.045. Epub 2010 Feb 26.
3
Nat Commun. 2019 Nov 27;10(1):5403. doi: 10.1038/s41467-019-13283-2.
4
Pediatric meningococcocal meningitis in the acute phase: how much does it cost?小儿急性期脑膜炎球菌性脑膜炎：需要花费多少？
Ital J Pediatr. 2019 Feb 13;45(1):25. doi: 10.1186/s13052-019-0616-z.
5
Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection.生物工程聚酯珠共展示蛋白和基于碳水化合物的抗原诱导针对细菌感染的保护性免疫。
Sci Rep. 2018 Jan 30;8(1):1888. doi: 10.1038/s41598-018-20205-7.
6
Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis.全合成自佐剂α-2,9-寡唾液酸基缀合物疫苗抗 C 群脑膜炎。
ACS Cent Sci. 2016 Apr 27;2(4):210-8. doi: 10.1021/acscentsci.5b00364. Epub 2016 Apr 4.
7
Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.α-2,9-寡唾液酸缀合物作为抗C群脑膜炎疫苗的合成与免疫学研究
Chem Commun (Camb). 2015 Jun 14;51(47):9647-50. doi: 10.1039/c5cc01794g.
8
Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.突变型天然外膜囊泡与A群多糖结合疫苗联合用于预防非洲脑膜炎球菌性流行病
PLoS One. 2013 Jun 21;8(6):e66536. doi: 10.1371/journal.pone.0066536. Print 2013.
9
Meningococcal disease: changes in epidemiology and prevention.脑膜炎奈瑟菌病：流行病学和预防的变化。
Clin Epidemiol. 2012;4:237-45. doi: 10.2147/CLEP.S28410. Epub 2012 Sep 19.
10
Improvement of immunogenicity of meningococcal lipooligosaccharide by coformulation with lipidated transferrin-binding protein B in liposomes: implications for vaccine development.通过在脂质体中与脂化转铁蛋白结合蛋白B共同配制提高脑膜炎球菌脂寡糖的免疫原性：对疫苗开发的意义。
Clin Vaccine Immunol. 2012 May;19(5):711-22. doi: 10.1128/CVI.05683-11. Epub 2012 Mar 21.
Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.
1998-2007 年美国脑膜炎奈瑟菌病流行病学变化：对预防脑膜炎球菌病的启示。
Clin Infect Dis. 2010 Jan 15;50(2):184-91. doi: 10.1086/649209.
4
Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages.一种新型四价脑膜炎球菌结合疫苗的化学性质，该疫苗在所有年龄段均具有免疫原性。
Vaccine. 2009 Sep 18;27(41):5574-80. doi: 10.1016/j.vaccine.2009.07.036. Epub 2009 Jul 18.
5
Global epidemiology of meningococcal disease.脑膜炎球菌病的全球流行病学
Vaccine. 2009 Jun 24;27 Suppl 2:B51-63. doi: 10.1016/j.vaccine.2009.04.063. Epub 2009 May 27.
6
Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa.用于非洲的免疫原性A群脑膜炎球菌结合疫苗的制备与特性分析
Vaccine. 2009 Jan 29;27(5):726-32. doi: 10.1016/j.vaccine.2008.11.065. Epub 2008 Dec 6.
7
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.一种四价脑膜炎球菌糖共轭疫苗在婴儿中的免疫原性：一项随机对照试验。
JAMA. 2008 Jan 9;299(2):173-84. doi: 10.1001/jama.2007.29-c.
8
A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.一种新型的b型流感嗜血杆菌- C群和Y群脑膜炎奈瑟菌-破伤风类毒素联合共轭疫苗具有免疫原性，在婴儿中与白喉-破伤风-无细胞百日咳-乙肝-灭活脊髓灰质炎疫苗以及共轭肺炎球菌疫苗共同接种时可诱导免疫记忆。
Vaccine. 2007 Dec 12;25(51):8487-99. doi: 10.1016/j.vaccine.2007.10.013. Epub 2007 Oct 25.
9
A universal vaccine for serogroup B meningococcus.一种针对B群脑膜炎球菌的通用疫苗。
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10834-9. doi: 10.1073/pnas.0603940103. Epub 2006 Jul 6.
10
Prospects for vaccine prevention of meningococcal infection.脑膜炎球菌感染疫苗预防的前景。
Clin Microbiol Rev. 2006 Jan;19(1):142-64. doi: 10.1128/CMR.19.1.142-164.2006.